|
FDA to Pull Only OTC Epinephrine Asthma Inhaler at Year-End
ProHealth FDA Public Announcement and Advice, March 16: The only over-the-counter asthma inhaler sold in the United States will no longer be available next year as part of an international agreement to stop the use of substances that damage the environment. … Only OTC asthma inhaler to be withdrawn from market |
View full post on asthma – Google News